ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2209

Stimulation of the Adenosine A2A Receptor (A2AR) Regulates the Expression of Netrin-1 (Ntn1) and Its Receptors (Unc5b, DCC) and Inhibits Wear Particle-Induced Inflammatory Osteolysis in a Model of Joint Prosthesis Loosening

Aranzazu Mediero1, Bhama Ramkhelawon2, Miguel Perez-Aso3, Kathryn Moore2 and Bruce Cronstein4, 1Medicine, Divison of Translational Medicine, NYU School of Medicine, New York City, NY, 2Leon H. Charney Division of Cardiology, Department of Medicine,, NYU School of Medicine, New York, NY, 3Provital S.A., Barberà del Vallès, Spain, 4Medicine, Division of Rheumatology, NYU School of Medicine, NEW YORK, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Adenosine receptors, Inflammation, osteoclastogenesis and prosthesis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Biology and Pathology of Bone and Joint: Bone Remodeling and Metabolism

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Ntn1 is a member of the family of axonal guidance proteins that plays a role in leukocyte function and inflammation and is critical for OC differentiation.  Because A2AR ligation, either directly or indirectly following methotrexate treatment, diminishes wear particle-induced inflammatory osteolysis we asked whether A2AR activation might regulate expression of Ntn1 at sites of inflammatory osteolysis.

Methods: 1cm midline sagittal incision was made over the calvaria in C57Bl/6 mice age 6-8 weeks. Mice received no particles (Control) or 3mg of UHMWPE wear particles with 20µl of saline 0.9% or CGS21680 (A2AR agonist, 1µM, n=4 each) at the surgical site every day for 14 days. After sacrifice, calvaria were prepared for immunostaining for Ntn1/Unc5b/DCC. Protein and mRNA expression were studied by RT-PCR and western blot in mouse primary bone marrow-derived OC and OB and in RAW264.7 cells (murine cell line) in the presence/absence of CGS21680 and ZM241385 (A2AR antagonist) 1µM each.

Results: Wear particles stimulated increased expression of Ntn1 and Unc5b, but not DCC, in periosteal inflammatory infiltrates, an effect which was blocked by the A2AR agonist CGS21680. In in vitro studies RANKL induced a 25±4 and 3±0.5 fold change, respectively, in Ntn1 and Unc5b mRNA during OC differentiation, changes that were completely blocked by CGS21680 (1.17±0.1, p<0.001, n=4). In contrast, DCC mRNA expression did not significantly change during OC differentiation and DCC expression was unaffected by CGS21680 (1.16±0.2 fold increase vs 1.9±0.2 for RANKL, p=ns, n=4). Similar changes were observed in protein expression and secretion. When Ntn1 or Unc5b were knocked-down in RAW264.7 cells using selective shRNA, basal mRNA expression for PKA, EPAC1 and EPAC2 (cAMP signaling molecules activated by A2AR) were increased and vice versa, when PKA, EPAC1 or EPAC2 were knocked down with selective shRNA, Ntn1 and Unc5b basal mRNA levels were increased. NFkB nuclear translocation was decreased in the presence of CGS21680 or in the absence of Ntn1. There was no change in Ntn1 or Unc5b expression during OB differentiation.

Conclusion: Ntn1 expression on macrophages and OC plays a central role in wear particle-induced osteolysis and adenosine A2AR stimulation downregulates Ntn1expression and inhibits bony destruction at sites of wear particle-induced osteolysis. Moreover, Ntn1-unc5b and A2AR stimulation reciprocally diminish signaling by each other. These results suggest that targeting Ntn1 directly or via stimulation of adenosine A2AR may be a novel approach to prevent osteolysis and joint prosthesis loosening.


Disclosure: A. Mediero, None; B. Ramkhelawon, None; M. Perez-Aso, None; K. Moore, None; B. Cronstein, Bristol-Myers Squibb, 5,Novartis Pharmaceutical Corporation, 5,Canfite Pharma, 5,Revive Therapeutics, 5,Regeneron, 5,Gismo Therapeutics, 5,Antares Pharmaceuticals, 5,Canfite Pharma, 1,Gilead Pharmaceuticals, 2,AstraZeneca, 2,Takeda, 2,Celgene, 2.

To cite this abstract in AMA style:

Mediero A, Ramkhelawon B, Perez-Aso M, Moore K, Cronstein B. Stimulation of the Adenosine A2A Receptor (A2AR) Regulates the Expression of Netrin-1 (Ntn1) and Its Receptors (Unc5b, DCC) and Inhibits Wear Particle-Induced Inflammatory Osteolysis in a Model of Joint Prosthesis Loosening [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/stimulation-of-the-adenosine-a2a-receptor-a2ar-regulates-the-expression-of-netrin-1-ntn1-and-its-receptors-unc5b-dcc-and-inhibits-wear-particle-induced-inflammatory-osteolysis-in-a-model-o/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/stimulation-of-the-adenosine-a2a-receptor-a2ar-regulates-the-expression-of-netrin-1-ntn1-and-its-receptors-unc5b-dcc-and-inhibits-wear-particle-induced-inflammatory-osteolysis-in-a-model-o/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology